Zoloft Patent Dispute: FTC Sides With Teva On Declaratory Judgment Rights
Executive Summary
The Federal Trade Commission is supporting Teva's effort to use the declaratory judgment process in patent litigation with Pfizer over Zoloft
You may also be interested in...
Declaratory Judgment Ruling Will Add Uncertainty To Generic Launches
Generic companies are likely to face an increased threat of patent infringement lawsuits on the eve of launch following an appeals court ruling on the standards for seeking a declaratory judgment of noninfringement
Declaratory Judgment Ruling Will Add Uncertainty To Generic Launches
Generic companies are likely to face an increased threat of patent infringement lawsuits on the eve of launch following an appeals court ruling on the standards for seeking a declaratory judgment of noninfringement
Pfizer Accupril Patent Victory Could Lead To Influx Of Generics In 2005
Accupril generics could enter the market as early as 2005 despite a court ruling finding a Pfizer quinapril patent to be valid